Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.

about

Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure.

Item

http://www.wikidata.org/entity/Q39016704

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Therapeutic drug monitoring of ...... d with a high rate of failure.

@en

Therapeutic drug monitoring of ...... d with a high rate of failure.

@nl

type

Item

label

Therapeutic drug monitoring of ...... d with a high rate of failure.

@en

Therapeutic drug monitoring of ...... d with a high rate of failure.

@nl

prefLabel

Therapeutic drug monitoring of ...... d with a high rate of failure.

@en

Therapeutic drug monitoring of ...... d with a high rate of failure.

@nl

P1476

Therapeutic drug monitoring of ...... ed with a high rate of failure

@en

P2093

Alain Le Moine

http://www.w3.org/2001/XMLSchema#string

Daniel Abramowicz

http://www.w3.org/2001/XMLSchema#string

Dimitri Mikhalski

http://www.w3.org/2001/XMLSchema#string

Frédéric Cotton

http://www.w3.org/2001/XMLSchema#string

Julien Coussement

http://www.w3.org/2001/XMLSchema#string

Karl M Wissing

http://www.w3.org/2001/XMLSchema#string

Laurette Maufort

http://www.w3.org/2001/XMLSchema#string

Nilufer Broeders

http://www.w3.org/2001/XMLSchema#string

P2860

Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review.

Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.

Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial.

Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.

Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.

Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.

Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.

P304

319-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFW001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Hougardy

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26985386

http://www.w3.org/2001/XMLSchema#string

P932

4792630

http://www.w3.org/2001/XMLSchema#string